6 May 2016
Director of the Purdue Center for Drug Discovery, Professor Philip S. Low, explains how advances in engineered T-cell therapy allow him to target tumors with improved selectivity, sensitivity and control, for enabling enhanced cancer immunotherapy.
Purdue Center for Drug Discovery
Professor Philip S. Low is Director of the Purdue Center for Drug Discovery - Biochemistry (Department of Chemistry). his laboratory focuses primarily on the development of ligand-targeted imaging and therapeutic agents for the diagnosis and treatment of important human diseases.